Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 122, 60-66
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- National Cancer Institute
This publication has 43 references indexed in Scilit:
- Comparison of three lymph node staging schemes for predicting outcome in patients with gastric cancerBritish Journal of Surgery, 2013
- Lymph node ratio predicts the benefit of post-operative radiotherapy in oral cavity cancerRadiotherapy and Oncology, 2013
- Using AIC in multiple linear regression framework with multiply imputed dataHealth Services and Outcomes Research Methodology, 2012
- Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular CarcinomaJournal of Clinical Oncology, 2011
- Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancerCancer, 2011
- Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification?Journal of Thoracic Oncology, 2011
- V‐CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trialsCancer, 2010
- Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancerThorax, 2010
- Model selection in ecology and evolutionTrends in Ecology & Evolution, 2004
- Residual‐based tree‐structured survival analysisStatistics in Medicine, 2001